Related references
Note: Only part of the references are listed.Pancreatic Ductal Adenocarcinoma Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a True R0 Resection?
Ioannis T. Konstantinidis et al.
ANNALS OF SURGERY (2013)
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
P. P. Provenzano et al.
BRITISH JOURNAL OF CANCER (2013)
MicroRNAs as potential biomarkers in human solid tumors
Jun Shen et al.
CANCER LETTERS (2013)
A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment
Minoti V. Apte et al.
GASTROENTEROLOGY (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
Yu-Quan Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma
Nazila Nouraee et al.
PLOS ONE (2013)
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
Andrea Vecchione et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Jessica Bockhorn et al.
NATURE COMMUNICATIONS (2013)
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Yun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Pancreatic cancer: why is it so hard to treat?
Paul E. Oberstein et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
The prognostic importance of miR-21 in stage II colon cancer: a population-based study
S. Kjaer-Frifeldt et al.
BRITISH JOURNAL OF CANCER (2012)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial
William F. Regine et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Boye Schnack Nielsen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
Y. Tomimaru et al.
BRITISH JOURNAL OF CANCER (2010)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
Kristi E. Allen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
Jin-Hyeok Hwang et al.
PLOS ONE (2010)
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Taiki Moriyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial
William F. Regine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Mary Dillhoff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
Membrane transporters and channels:: Role of the transportome in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2004)
Share Paper
